Denali Therapeutics Inc
NASDAQ:DNLI

Watchlist Manager
Denali Therapeutics Inc Logo
Denali Therapeutics Inc
NASDAQ:DNLI
Watchlist
Price: 20.8262 USD -2.91%
Market Cap: 3B USD
Have any thoughts about
Denali Therapeutics Inc?
Write Note

Revenue Breakdown

Breakdown by Geography
Denali Therapeutics Inc

Not Available

Breakdown by Segments
Denali Therapeutics Inc

Total Revenue: 330.5m USD
100%
Atv:abeta Program License: 288.9m USD
87.4%
Cns Program License: 25m USD
7.6%
Ptv:pgrn Collaboration Agreement: 10m USD
3%
Option Research Services: 1.6m USD
0.5%
Show More
Show Less

See Also

Discover More